Skip to main content

Day: February 6, 2024

Progress Enables Developers to Accelerate Application Modernization with Latest Release of OpenEdge

With new features such as incremental build support, OpenTelemetry integration and dynamic data masking, developers can build robust, more secure business applications while optimizing performance BURLINGTON, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of infrastructure software, today announced the latest release of Progress® OpenEdge®, the flagship application development platform used by over 100,000 customers across the globe to simplify the delivery of mission-critical business applications. By leveraging the new features and enhancements of OpenEdge 12.8, organizations can optimize their development processes, improve database performance, enhance application security and stay current with the evolving technology landscape. “For decades, Progress has provided the technology businesses...

Continue reading

Catapult Revolutionizes Women’s Hockey by Collaborating with Professional Women’s Hockey League

League-wide deal equips all PWHL teams with Catapult video solutions to enhance their game strategies and performance analysis Boston, MA, Feb. 06, 2024 (GLOBE NEWSWIRE) — Catapult (ASX: CAT), the global performance technology leader in elite sports, today announced a new partnership with the Professional Women’s Hockey League (PWHL). For the first time ever, Catapult is working with a professional women’s hockey organization to help improve various aspects of the athletes’ performance, training, analysis, and overall experience. The new league-wide collaboration will empower all six PWHL teams (Boston, Minnesota, Montreal, New York, Ottawa, and Toronto) with Catapult’s cutting-edge video solutions to enhance game strategies and performance analysis. The integration of Catapult’s video solutions allows PWHL teams to conduct in-depth...

Continue reading

AMD Unveils Embedded+ Architecture; Combines Embedded Processors with Adaptive SoCs to Accelerate Time-to-Market for Edge AI Applications

AMD Embedded+ ArchitectureAMD Embedded+ architecture combines AMD Ryzen™ Embedded processors with Versal™ adaptive SoCs onto a single integrated board to deliver scalable and power-efficient solutions that accelerate time-to-market.— AMD-validated solutions provide a simplified path to AI inferencing, sensor fusion, industrial networking, control, and visualization for ODM partners — SANTA CLARA, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) today announced the launch of AMD Embedded+, a new architectural solution that combines AMD Ryzen™ Embedded processors with Versal™ adaptive SoCs onto a single integrated board to deliver scalable and power-efficient solutions that accelerate time-to-market for original design manufacturer (ODM) partners. Validated by AMD, the Embedded+ integrated...

Continue reading

MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS

MangoRx Wants to Keep Fumbles on the Field, Not in the Bedroom, Offering the Losing Team Free MangoRx ED Products for One Year Dallas, Texas, Feb. 06, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (“GROW”) and erectile dysfunction (“ED”) drug (“Mango”), announces that regardless of who loses the Big Game this Sunday, they are prepared to offer a free one-year supply of its Mango ED products for the entire losing team, ensuring they still get sacked after the game. MangoRx is committed to helping men tackle hard issues. In addition to offering the losing team players the opportunity to score, fans...

Continue reading

Splash Beverage Group, Inc. Secures Major Partnership with Sea World Parks & Entertainment

FORT LAUDERDALE, FL, Feb. 06, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today is pleased to announce a significant milestone in its growth journey with the addition of Sea World Parks & Entertainment to its growing list of large venue customers. Sea World Parks & Entertainment, a renowned leader in family entertainment and education, will now offer Splash Beverage Group’s Pulpoloco Sangria in all of its parks across California, Florida, Pennsylvania, Virginia, and Texas. This opportunity supports Splash Beverage Group’s position as a premier provider of high-quality beverages and underscores its commitment to expanding its footprint in key markets. “We are excited to have been...

Continue reading

Bridgetown, Barbados Credit Union Selects BIO-key’s PortalGuard to Enhance Access to Shared Workstations Including Biometrics

BRIDGETOWN, Barbados and HOLMDEL, N.J., Feb. 06, 2024 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of passwordless, phoneless, and token-less Identity and Access Management (IAM) Multifactor Authentication (MFA) solutions, announced that the City of Bridgetown Co-operative Credit Union Ltd. (COB) has selected BIO-key’s PortalGuard platform with Identity-Bound Biometrics (IBB), to transform its secure login methodologies for staff access to critical systems and data. COB has multiple locations supporting more than 60,000 members in Barbados. By implementing BIO-key’s PortalGuard platform with Identity-Bound Biometric authentication, COB ensures a more robust and reliable defense against unauthorized access to the credit union’s systems. Project requirements included meeting or exceeding...

Continue reading

Getty Images Announced as Official Photographer of 2024 Fall/Winter NYFW: The Shows

A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, has once again been named as the Official Photographer for the 2024 Fall/Winter Season of IMG’s New York Fashion Week (NYFW): The Shows. As the Official Photographer, Getty Images’ award‑winning entertainment photographers will be delivering high‑quality content throughout New York Fashion Week (February 9-14) in New York City, all to be distributed exclusively through gettyimages.com. This includes covering all shows at RXR’s Starrett-Lehigh building and Fashion Alliance runway shows and presentations, as well as all off-site IMG FOCUS. produced shows, and the first-ever NYFW consumer venue at 21Greene, home to official...

Continue reading

Arhaus Unveils Second Volume of Its Editorial Series Storied, ‘Bellissimo Segreto’

‘Bellissimo Segreto’ – or, “A Beautiful Secret” – pays homage to Arhaus’ artisan partners throughout Italy and the creative process behind the brand’s beloved Italian collectionsArhaus ‘Bellissimo Segreto’Arhaus ‘Bellissimo Segreto’BOSTON HEIGHTS, Ohio, Feb. 06, 2024 (GLOBE NEWSWIRE) — Arhaus (NASDAQ: ARHS), a leader in artisan-crafted and responsibly sourced home furnishings, debuts ‘Bellissimo Segreto,’ the second volume of its editorial series Storied, a compilation of imagery and storytelling developed to commemorate the brand’s artisan partnerships built over the years. Since its inception in 1986, Arhaus has traveled the world to forge enduring relationships with vendors, driven by a commitment to source products directly from the talented craftspeople who create them. In addition...

Continue reading

Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain

First study ever to evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer On track to commence enrollment in Q1 2024 THE WOODLANDS, TX, Feb. 06, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it has received authorization from the Uzbekistan Ethics Committee to open the clinical trial site for its proof-of-concept human clinical study evaluating the use of transvascular ablation for the treatment of pancreatic cancer pain. The Company is on track to commence enrollment in the first quarter of 2024. “Our team remains focused on the successful...

Continue reading

New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812

NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that collaborators at the University of Edinburgh, Scotland published findings in the journal, Acta Neuropathologica, (doi: 10.1007/s00401-023-02679-6) that provide new insight into the biology of Alzheimer’s disease that is consistent with our understanding of the role the σ-2 receptor has in regulating Aβ oligomer binding.  Using a combination of two high-resolution microscopy techniques: array tomography and Förster resonance energy transfer (FRET), Professor Tara Spires-Jones and colleagues at the UK Dementia Research Institute at University of Edinburgh’s Centre for Discovery Brain Sciences analyzed protein-protein interactions in over 1 million...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.